Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2005
11/16/2005EP1511839A4 Generation of neural stem cells from undifferentiated human embryonic stem cells
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1399568B1 Method for producing recombinant trypsin
11/16/2005EP1315805B1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
11/16/2005EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS
11/16/2005EP1082423B1 Cyclin e2 genes and proteins
11/16/2005EP1019493B1 Generation of hematopoietic cells from multipotent neural stem cells
11/16/2005EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
11/16/2005EP0939799B1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase
11/16/2005EP0749491B1 Enhanced expression in a plant plastid
11/16/2005EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/16/2005EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor
11/16/2005CN2740615Y Food steamer style liquid nitrogen freezing storing box
11/16/2005CN1696283A Serum-free medium suitable to culturing ovary cells of Chinese hamster
11/16/2005CN1227363C Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/16/2005CN1227362C Biosynthetic genes for spinosyn insecticide production
11/16/2005CN1227356C Application of substrate cell derived from fat tissue
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/16/2005CN1227033C Method of treating cancer with anti-neurotrophin agents
11/16/2005CN1227031C Application of varicella-zoster-virus for preparing varicella preventing medicine
11/15/2005US6965063 Genetic engineering; insect and herbicide resistant corn
11/15/2005US6965024 Reactive with ganglioside GD3; cancer treatment
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6964957 For use in therapy of neurodegenerative diseases and certain cancers
11/15/2005US6964869 Polypeptides; detecting infections using antibodies
11/15/2005US6964868 Human polynucleotides; genetic engineering
11/15/2005US6964854 Using monoclonal antibody; hybridomas cell line
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005CA2162481C Marker gene
11/15/2005CA2155533C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105996A1 A pax-encoding vector and use thereof
11/10/2005WO2005105992A1 Chondrocyte culture formulations
11/10/2005WO2005105991A1 Amp deaminase originating in streptomyces and utilization thereof
11/10/2005WO2005105986A2 Neural cell differentiation method from es cells
11/10/2005WO2005105985A1 Methods for stem cell expansion and differentiation
11/10/2005WO2005105984A2 Culture conditions and growth factors affecting fate determination, self-renewal and expansion of mouse spermatogonial stem cells
11/10/2005WO2005105983A1 Use of the aca glycoprotein for obtaining/maintaining pluripotent non-embryonic stem cells
11/10/2005WO2005105982A1 Method for the ex vivo sequential expansion of human postembryonic stem cells and subsequent selective differentiation
11/10/2005WO2005105981A2 Method and system for reinnervation of muscle
11/10/2005WO2005105850A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
11/10/2005WO2005105846A1 Antibody specifically recognizing resin plasticizer compound
11/10/2005WO2005104755A2 Artificial immune system: methods for making and use
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005082932A3 Compositions and methods using rna interference for control of nematodes in plants
11/10/2005WO2005055877A3 Method for the production of intervertebral disk tissue from degenerate intervertebral disk tissue
11/10/2005WO2005009222A3 Method of determining sperm capacitation
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2003082201A3 Collagen biofabric and methods of preparation and use therefor
11/10/2005US20050251885 Method for enhancing yield of recombinant protein production from plants
11/10/2005US20050251883 Dwarfism genes and dwarf plants
11/10/2005US20050251882 Sucrose phosphate synthase nucleic acid molecules and uses therefor
11/10/2005US20050251881 Carotenoid ketolase gene
11/10/2005US20050251875 Transgenic plants with tocopherol methyltransferase
11/10/2005US20050251873 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251267 Cell permeable structural implant
11/10/2005US20050250938 Isolated gamma coixin promoter comprising specified nucleic acid sequence
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250687 Anti-tumor activity of Ea-4-peptide of pro-IGF-I
11/10/2005US20050250681 Treatment of ocular diseases and disorders using lantibiotic compositions
11/10/2005US20050250207 Retrons for gene targeting
11/10/2005US20050250206 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250202 Adipose stromal stem cells for tissue and vascular modification
11/10/2005US20050250197 Microinjection device and microinjection method
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250177 Preparation, characterization and quantification of active fractions that promote cell growth and recombinant-protein expression
11/10/2005US20050250161 inducing tolerance to xenograft tissue or organ; tolerogenic antigen presenting cells (APC) which overexpress monocyte inhibitory receptor (MIR); generating antigen specific allospecific human-suppressor CD8+CD28- T cells; detecting expression of ILT3, ILT4, ILT2 protein; autoimmune diseases; host cell
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250153 Novel fetal genes
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250133 Molecular interaction sites of 16S ribosomal RNA and methods of modulating the same
11/10/2005US20050250105 Multiple viral replicon culture systems
11/10/2005US20050250088 Cryopreservation media
11/10/2005US20050249816 producing a decellularized a liver; can be used to reconstruct the artificial organ; use of decellularizing solution containing a detergent such as Triton X100 and ammonium hydroxide
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249726 Useful as therapeutic agent and diagnostic tool for brain tumors which strongly express antigen that is recognized by this antibody
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249708 Cerebral Intraventricular Transplantation as Method of Treating Amyotrophic Lateral Sclerosis (ALS)
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005DE102005018644A1 Implant for treatment of defects in long bone, comprises layers of flat, bioresorbable material, adapted to the shape of the defect, having porosity that allows entry of cells and blood vessels
11/10/2005DE102004025081B4 Multizelluläre Gewebe- und Organkultursysteme Multicellular tissue and organ culture systems
11/10/2005DE102004019662A1 Pharmaceutically active substance, useful for treating tumors e.g. skin cancers, comprises dendritic cells of e.g. spinal marrow (loaded with toxins of spiders of the family Pholcidae) cultivated in the presence of interleukin
11/10/2005DE102004019323A1 Mit toxischen Substanzen beladene dendritische Zellen zur Behandlung von Nierenzellkarzinomen With toxic substances loaded dendritic cells for the treatment of renal cell carcinoma
11/10/2005DE102004018608A1 Doppelt transfizierte Zellinien als in-vitro-Screening-Werkzeuge zur Erstellung von Profilen pharmazeutischer Verbindungen:Ein Modell für die hepatobiläre Elimination Double-transfected cell lines as in vitro screening tools for creating profiles pharmaceutical compounds: A model for the hepatobiliary elimination
11/10/2005DE10006033B4 Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen Immunizing an individual against carcinomas and their precursors
1 ... 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 ... 1827